Works from 2020
Crowdsourcing a crisis response for COVID-19 in oncology, Aakash Desai, Jeremy Warner, Nicole Kuderer, et al. (Article)
MET receptor in oncology: from biomarker to therapeutic target, Raeva Malik, Isa Mambetsariev, Jeremy Fricke, et al. (Article)
Primary epithelioid angiosarcoma of the uterus: a rare tumor with very aggressive behavior, Nasma K Majeed, Brian Adley, Grace Guzman, et al. (Article)
Works from 2019
Sexual quality of life after the treatment of gynecologic cancer: what women want, J L Hubbs, Elizabeth L. Dickson Michelson, R I Vogel, et al. (Article)
Ibrutinib and rituximab provides superior clinical outcome compared to FCR in younger patients with chronic lymphocytic leukemia (CLL): Extended follow-up from the E1912 trial, Tait D Shanafelt, Victoria Wang, Neil E Kay, et al. (Article)
TP53 status as a determinant of pro- versus anti-tumorigenic effects of estrogen receptor-beta in breast cancer, Utpal K Mukhopadhyay, Chetan C Oturkar, Christina Adams, et al. (Article)
Squamous cell carcinoma of the tongue with metastasis to myocardium: Report of a case and literature review, Ali Shafiq, Fatima Samad, Eric Roberts, et al. (Article)
American Urological Association non-muscle invasive bladder cancer risk model validation: should patient age be added to the risk model?, Kourosh Ravvaz, John A Weissert, and Tracy M Downs (Article)
ASCO Research Community Forum: Impact on clinical research, David M. Waterhouse, Nicholas J. Robert, Edward S. Kim, et al. (Abstract)
Ibrutinib-rituximab or chemoimmunotherapy for chronic lymphocytic leukemia, Tait D Shanafelt, Xin V Wang, Neil E Kay, et al. (Article)
Organizing online health content: developing hashtag collections for healthier internet-based people and communities, Matthew S Katz, Patricia F Anderson, Michael A. Thompson, et al. (Article)
Oncology precision medicine for hepatobiliary and pancreatic cancer: An institutional review, Geoffrey Bellini, Jennifer Godden, James Weese, et al. (Abstract)
Physiological and psychosocial effects of a highly structured exercise program on breast cancer survivorship, Judy A. Tjoe, Linda B Piacentine, Jun Yin, et al. (Abstract)
Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital: Focus on cardiovascular patients, Reid Christian Bowers, Sandra Tomany Korman, Michael A. Thompson, et al. (Abstract)
Use of treatment pathways reduce cost and decrease ED utilization and unplanned hospital admissions in patients (pts) with stage II breast cancer, James Weese, Corey J. Shamah, Federico A. Sanchez, et al. (Abstract)
Variability in sentinel lymph node biopsy retrieval for breast cancer at Aurora Health Care, Aaron H. Chevinsky, Judy A. Tjoe, William L. Owens, et al. (Abstract)
Epidemiology of male breast cancer, Santhi Konduri, Maharaj Singh, George C. Bobustuc, et al. (Abstract)
Evaluation of Sox2 expression in glioblastoma stem cells during zika virus infection, Beau Adams, Sam D. Zwernik, Amin Kassam, et al. (Abstract)
No-cost next generation sequencing of advanced cancer patients within the Strata Precision Oncology Network supports clinical trial enrollment, Marc Ryan Matrana, Scott A. Tomlins, Kat Kwiatkowski, et al. (Abstract)
Lymphedema precautions: When are they required? A literature review, Michelle Grube (Poster)
p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression, Judy A. Tjoe, Brittany S. Last, and Jun Yin (Abstract)
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma, Caitlin Costello, Faith E Davies, Gordon Cook, et al. (Article)
Mo1412 – Oncologic outcomes of robotic compared to open pancreatic surgery: A national cancer database participant user file study, Geoffrey Bellini, Maharaj Singh, James Weese, et al. (Abstract)
Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass, Haiyan Bao, Juehua Gao, Yi-Hua Chen, et al. (Article)
C-reactive protein in HPV-positive and HPV-negative oropharyngeal cancer, Stephanie Johnson-Obaseki, Lisa Caulley, Martin Corsten, et al. (Article)
Determining value of a precision medicine program in a vertically integrated healthcare system, James Weese, Michael A. Thompson, and Jennifer Godden (Oral/Podium Presentation)
Racial disparity in gastrointestinal cancer: insight from national cancer database, Maharaj Singh, Samit K. Datta, Wesley Papenfuss, et al. (Abstract)
Survival outcomes between surgery with adjuvant therapy compared to neoadjuvant therapy with surgery in stage I pancreatic adenocarcinoma: Results from a large national cancer database, Samit K. Datta, Geoffrey Belini, Maharaj Singh, et al. (Abstract)
Survival outcomes comparable between endoscopic resection and surgical resection, Samit K. Datta, Geoffrey Belini, Maharaj Singh, et al. (Abstract)
Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One, Michael A. Thompson, Jennifer J. Godden, Deborah Wham, Antony Ruggeri, Michael P. Mullane, Amanda Wilson, Shamsuddin Virani, Scott M. Weissman, Brenda Ramczyk, Pamela Vanderwall, and James L. Weese (Review)
Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis, Victor M Lu, Anshit Goyal, Richard A. Rovin, et al. (Article)
Works from 2018
Social media and clinical trials: The pros and cons gain context when the patient is at the center, Michael A. Thompson and Ruth M O'Regan (Article)
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) on social media: #BPDCN-increasing exposure over two years since inception of a disease-specific twitter community, Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al. (Article)
Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome, Matthew Walters, Mark R Pittelkow, Robert P Hasserjian, et al. (Article)
Promoting team-based exercise among African American breast cancer survivors, Linda B Piacentine, Karen M Robinson, Leslie J. Waltke, et al. (Article)
Non-human papillomavirus cervical mucinous adenocarcinoma in a phenotypic male with congenital adrenal hyperplasia, Jennifer Heim, Elizabeth L. Dickson, Melissa Aa Geller, et al. (Article)
Precision medicine/genetics: Advocate Aurora Health cancer screening updates for the primary care clinician, Michael A. Thompson and Michael P. Mullane (Oral/Podium Presentation)
Can we improve nonmuscle invasive bladder cancer guideline adherence with smarter risk stratification?, Tracy M Downs, John Weissert, and Kourosh Ravvaz (Editorial)
A global treatment standard in multiple myeloma (MM) remains elusive despite advances in care over 15 years: first results from INSIGHT MM, the largest global prospective, observational MM study, Caitlin L. Costello, Mario Boccadoro, Michael A. Thompson, et al. (Abstract)
Differential regulation of human monocytes and NK cells by antibody-opsonized tumors, Jun Yin, Alex J. Albers, Thomas S. Smith, et al. (Article)
Racial Disparity Among Women Diagnosed With Invasive Breast Cancer in a Large Integrated Health System, Maharaj Singh, Santhi D. Konduri, George C. Bobustuc, Amin B. Kassam, and Richard A. Rovin (Original Research)
Decreased trend in hospital mortality from pancreatic cancer despite increase in number of hospital admissions, Sanjay Bhandari, Mubeen Khan Mohammed Abdul, Will Hollabaugh, et al. (Article)
MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and survivin inhibition and enhances response to temozolomide, George C. Bobustuc, Amin B. Kassam, Richard Rovin, et al. (Article)
The survival effect of repeat surgery at glioblastoma recurrence and its trend: a systematic review and meta-analysis, Victor M Lu, Toni R Jue, Kerrie L McDonald, et al. (Article)
One pulmonary lesion, 2 synchronous malignancies, Masooma Aqeel, Nevin Uysal-Biggs, Timothy S Fenske, et al. (Article)
Implementing precision medicine programs and clinical trials in the community-based oncology practice: barriers and best practices, J L. Ersek, L J. Black, Michael A. Thompson, et al. (Book Chapter)
Drug targeting: repurposing FDA therapeutic drugs to treat triple-negative breast cancer, Paul J. Mintz, Jerald Smith, Andrea Sand, et al. (Abstract)
Initiation of a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) program at Aurora Health Care, Aaron H. Chevinsky, Wesley Papenfuss, Federico A. Sanchez, et al. (Abstract)
Identification, prioritization, and treatment of mutations identified by next-generation sequencing, Aaron S Mansfield, Ben Ho Park, and Michael P. Mullane (Book Chapter)
Implementing precision medicine programs and clinical trials in the community-based oncology practice: barriers and best practices, Jennifer L Ersek, Lora J Black, Michael A. Thompson, et al. (Book Chapter)
Multidisciplinary management of oligometastatic soft tissue sarcoma, Juneko E Grilley-Olson, Nicholas P. Webber, David S. Demos, et al. (Book Chapter)
The effects of checkpoint blockade and a CD40 agonist on T-independent and T-dependent antibody responses in mice: implications for optimization of vaccination strategies in patients receiving immunotherapies, Karen Michel, Ashley Gehrand, Michael A. Thompson, et al. (Article)
The effects of checkpoint blockade and a CD40 agonist on T-independent and T-dependent antibody responses in mice: implications for optimization of vaccination strategies in patients receiving immunotherapies, Karen Michel, Ashley Gehrand, Michael A. Thompson, et al. (Article)
Drug-specific videos for patient chemotherapy education, James Weese, Kerry A. Twite, Marija Bjegovich-Weidman, et al. (Article)
RETRACTED: Sentinel lymph node mapping in endometrioid endometrial cancer: does it work in the real world? [22A], Olga Valieva, Danielle M. Greer, Jessica J. Kram, et al. (Abstract)
The Needs of Women Treated for Ovarian Cancer: Results From a #gyncsm Twitter Chat, Teresa Hagan Thomas, Karin Nauth-Shelley, Michael A. Thompson, Deanna J. Attai, Matthew S. Katz, David Graham, Dee Sparacio, Christina Lizaso, Audun Utengen, and Don S. Dizon (Original Research)
BRD4 inhibition Is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency, Chaoyang Sun, Jun Yin, Yong Fang, et al. (Article)
Androgen deprivation therapy for prostate cancer and incident atrial fibrillation, Zuber S. Ali, Tadele Mengesha, Suhail Allaqaband, et al. (Poster)
Metastatic recurrent hepatocellular carcinoma post liver transplant with marked pretransplant elevation of alpha fetoprotein and no evidence of primary neoplasm, Shiva Kumar (Article)
Association of 70-gene signature assay findings with physicians' treatment guidance for patients with early breast cancer classified as intermediate risk by the 21-gene assay, Michaela Tsai, Shelly Lo, William Audeh, et al. (Article)
Factors influencing first-line therapy of acute myeloid leukemia (AML) patients (pts) in the Connect MDS/AML Disease Registry, Christopher R Cogle, Michael A. Thompson, and et al (Abstract)
Lower extremity weakness in an adolescent female - a rare presentation of Ewing sarcoma, Luke Addesso, David Koenig, and Nadia Huq (Article)
Quantifying the effect of air gap, depth, and range shifter thickness on TPS dosimetric accuracy in superficial PBS proton therapy, Robert J. Shirey and Hsinshun Terry Wu (Article)
Reportable actionability versus pragmatic actionability: Implementing precision medicine at three large health systems, Michael A. Thompson, James Weese, Maharaj Singh, et al. (Abstract)
Successful automated normalization of cancer outcomes for half a million patients across four disparate health systems, Paul D. Tittel, Michael A. Thompson, James Weese, et al. (Abstract)
Works from 2017
Generation of a Patient-Derived Brain Metastasis Breast Cancer Cell Line via Novel Orthotopic Injection Placement and Serial Mouse Transplantation to Develop PDX Mouse Model, Amber L. LaCrosse, Denise M. Coley, Paul J. Mintz, Santhi D. Konduri, Richard A. Rovin, and Amin B. Kassam (Supplement)
Robustness of a Newly Proposed Risk Schema for Lymphatic Dissemination in Endometrioid Endometrial Cancer, Danielle M. Greer, Jessica J.F. Kram, Callie M. Cox Bauer, and Scott A. Kamelle (Supplement)
Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response, Michael A. Thompson, Martin K. Oaks, Maharaj Singh, Karen M. Michel, Michael P. Mullane, Husam S. Tarawneh, Angi Kraut, and Kayla J. Hamm (Brief Report)
Analysis of the use and impact of Twitter during American Society of Clinical Oncology annual meetings from 2011 to 2016: Focus on advanced metrics and user trends, Naveen Pemmaraju, Michael A. Thompson, Ruben A Mesa, et al. (Article)
The emerging role of professional social media use in oncology, Mina S Sedrak, Don S Dizon, Patricia F Anderson, et al. (Editorial)
Disulfram enhances Palbociclib and Abemaciclib activity through MGMT and CDK4/6 inhibition in breast cancer cells, Santhi Konduri, Deborah Donohoe, Dmitry Bosenko, et al. (Poster)
Robustness of a newly proposed risk schema for lymphatic dissemination of endometrioid endometrial cancer, Danielle M. Greer, Jessica J F Kram, Callie M. Cox Bauer, et al. (Poster)
Hormonal contraception and therapy use in breast cancer survivors: Do recurrence and mortality risks increase?, Sara Stanenas, Danielle M. Greer, Jessica J F Kram, et al. (Abstract)
Triathlon training for women breast cancer survivors: feasibility and initial efficacy, Alexander V Ng, Alyson N Cybulski, Ashley A Engel, et al. (Article)
Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study, Andinet Alemu, Maharaj Singh, Chris Blumberg, John O. Richards, Martin K. Oaks, and Michael A. Thompson (Original Research)
Predicting nonmuscle invasive bladder cancer recurrence and progression in a United States population, Kourosh Ravvaz, Marcus E Walz, John Weissert, et al. (Article)
Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553), Susanne M Arnold, Kari Chansky, Markos Leggas, et al. (Article)
BRE12-158: A phase II randomized controlled trial of genomically directed therapy after preoperative chemotherapy in patients with triple negative breast cancer (TNBC), B Schneider, K D. Miller, S Badve, et al. (Abstract)
Enhanced recovery program and length of stay after laparotomy on a gynecologic oncology service: A randomized controlled trial, Elizabeth L. Dickson, Erica Stockwell, Melissa A Geller, et al. (Article)
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment, Jeffrey S Weber, Laura A Levit, Peter C Adamson, et al. (Article)
Best practices and practical nuances in the treatment of gastric cancer in high-risk global areas, Federico A. Sanchez (Article)
Competitive funding strategies for the conquer cancer foundation of ASCO, Tanios Bekaii-Saab, Sanjay Goel, Adrien Dickerson, et al. (Article)
Practice model for advanced practice providers in oncology, Jamie Cairo, Mary Ann Muzi, Deanna Ficke, et al. (Article)
Works from 2016
Current diagnosis patterns for acute myeloid leukemia (AML) in clinical practice compared with World Health Organization (WHO) 2008 recommendations: outcomes from the CONNECT® Myelodysplastic Syndromes (MDS) and AML disease registry, Tracy I. George, Harry P. Erba, David P. Steensma, et al. (Abstract)
Global, prospective, non-interventional, observational study of presentation, treatment patterns, and outcomes in multiple myeloma patients: the Insight-MM Study, Robert M. Rifkin, Faith E. Davies, Antonio Palumbo, et al. (Abstract)
Multiple myeloma vaccination sequential immune response pilot study, Michael A. Thompson, Martin K. Oaks, John O Richards, et al. (Abstract)
Social media and myeloproliferative neoplasms (mpn): analysis of advanced metrics from the first year of a new twitter community: #mpnsm, Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al. (Article)
The impact of perioperative β blocker use on patient outcomes after primary cytoreductive surgery in high-grade epithelial ovarian carcinoma, Ahmed Al-Niaimi, Elizabeth L. Dickson, Cassandra Albertin, et al. (Article)
Determining the Incidence and Factors of Cardiotoxicity in Breast Cancer Patients Treated With Anthracycline and/or Trastuzumab-Containing Regimen at Aurora Health Care, Stephanie Ghojallu, Matthew Rappelt, Han-Yang Chen, Ruth Perez, Lydia Garlie, Geoffrey Riddell, Yingying Gu, Jun Zhang, Rubina Qamar, Bijoy K. Khandheria, Arshad Jahangir, and Yang Shi (Supplement)
Erratum to: NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells, John O Richards, Alex J. Albers, Thomas S. Smith, et al. (Article)
NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells, John O Richards, Alex J. Albers, Thomas S Smith, et al. (Article)
Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: A meta-analysis, Zeeshan Jawa, Ruth M Perez, Lydia Garlie, et al. (Article)
Measures of appropriateness and value for breast surgeons and their patients: the american society of breast surgeons choosing wisely (®) initiative, Jeffrey Landercasper, Lisa Bailey, Tiffany S Berry, et al. (Article)
New primary palliative care (PC) model for community cancer clinics (CCC), Cheruppolil R. Santhosh-Kumar, Deborah Gray, Stephanie Struve, et al. (Abstract)
Addressing administrative and regulatory burden in cancer clinical trials: Summary of a stakeholder survey and workshop hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes, Julie M Vose, Laura A Levit, Patricia Hurley, et al. (Article)
Breast cancer diagnosed by stress SPECT sestamibi: The role of inverse gray-scale imaging, Khawaja Afzal Ammar, Armaan Shaikh, Michael Anigbogu, et al. (Article)
Extradigital glomus tumor: a rare etiology for wrist soft tissue mass, Justin E. Friske, Vipul Sharma, S A. Kolpin, et al. (Case Report)
Insights from building a new National Cancer Institute Community Oncology Research Network Program site, Thomas J. Saphner, Michael A. Thompson, Sara Planton, et al. (Article)
New insights into estrogenic regulation of O(6)-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O(6)-benzylguanine indicates fresh avenues for therapy, Ameya Paranjpe, Nathan I Bailey, Santhi Konduri, et al. (Article)
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study, David P Steensma, Medrdad Abedi, Rafael Bejar, et al. (Article)